ClinicalTrials.Veeva

Menu

Special Investigation Of J Zoloft For Panic Disorder Patients

Viatris logo

Viatris

Status

Completed

Conditions

Panic Disorder

Treatments

Drug: Sertraline hydrochloride

Study type

Observational

Funder types

Industry

Identifiers

NCT00605917
A0501092

Details and patient eligibility

About

The objective of this surveillance is to collect information for panic disorder patients about 1) adverse drug reactions not expected from the LPD (unknown adverse drug reactions), 2) the incidence of adverse drug reactions in this surveillance, and 3) factors considered to affect the safety and/or efficacy of this drug.

Full description

All patients with panic disorder to whom an investigator prescribes the first sertraline hydrochloride should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into the investigation at random.

Enrollment

997 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients with panic disorder need to be taking sertraline hydrochloride in order to be enrolled in the surveillance.

Exclusion criteria

Patients not taking sertraline hydrochloride.

Trial design

997 participants in 1 patient group

Sertraline hydrochloride.
Description:
The patients of Panic disorder taking Sertraline hydrochloride.
Treatment:
Drug: Sertraline hydrochloride

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems